The future of checkpoint kinase research is promising, with ongoing studies aimed at better understanding their role in cancer biology and developing more effective inhibitors. Advances in genetic and molecular profiling are helping to identify patients who are most likely to benefit from checkpoint kinase inhibitors. Additionally, combination therapies that include checkpoint kinase inhibitors are being explored to enhance treatment efficacy and overcome resistance.
